IMMY hosted Klaus Hochleitner of Cytiva for an intensive hands-on lateral flow assay workshop and presentation.

Fungal Diagnostics for a Healthier Tomorrow. IMMY is a U.S.-based developer and manufacturer of fungal and infectious disease diagnostics. Headquartered in Norman, Oklahoma since 1979, we design, manufacture, and distribute affordable and reliable diagnostic tests that bridge the gap between patients and the care they urgently need. We are committed to addressing the global challenges of delayed, inaccurate, and inaccessible fungal diagnostics — delivering innovative, high-quality solutions that help connect the right information to the right people at the right time. We are also committed to antifungal stewardship, supporting the responsible use of antifungal therapies through accurate and timely diagnostics. By enabling early detection across a broad range of fungal pathogens, we empower healthcare providers to make informed treatment decisions and help connect patients to proper care sooner — supporting quality care in over 100 countries. Our values — humble, driven, and collaborative — shape everything we do, from how we develop our products to how we serve our global partners and customers. Join us in shaping the future of global health.

Founded 1979